Thomson, M. A.; Hall, S.; Fritscher-Ravens, A.; Swain, P.
April 2004
Gut;Apr2004 Supplement 3, Vol. 53, pA10
Academic Journal
The aim of this work is to assess the medium term efficacy of the BARD Endocinch device for the treatment of gastro-oesophageal reflux disease (GORD) in children and adolescents. 17 males with symptoms of GORD dependent on proton pump inhibitors (PPI) for greater than 12 months or refractory to PPIs underwent endoscopic gastroplication (EG), and follow up occurred bra median of 15 months. Symptom scoring, upper gastrointestinal endoscopy, oesophageal manometry, gastric scintiscan, 24 hour oesophageal pH, and completed reflux quality of life were at 0, 6 and 52 weeks. This is the first study reporting paediatric experience with an endoscopic anti-reflux procedure and demonstrates medium term sustained efficacy in managing GORD in children.


Related Articles

  • DOES ENDOSCOPY ALTER MANAGEMENT FOR SIMPLE REFLUX DISEASE. Turner, G. B.; Tham, T. C. K. // Gut;Apr2004 Supplement 3, Vol. 53, pA10 

    The role of endoscopy for patients with simple gastro-oesophogeal reflux disease is unclear particularly under the age of 55 years. Authors report the influence of endoscopy on the management of 100 patients with uncomplicated reflux symptoms. Endoscopy for simple reflux symptoms led to a change...

  • A review of proton-pump inhibitors. Smith, Haley // South African Pharmaceutical Journal;2014, Vol. 81 Issue 5, p13 

    The introduction of proton-pump inhibitors (PPIs) in the late 1980s optimised the medical treatment of acid-related disorders. PPIs have superseded the use of histamine-2-receptor antagonists in patients with moderate to severe gastric acid-related diseases, as well as for the prophylaxis of...

  • Continuing Medical Education: July 2011.  // American Journal of Gastroenterology;Jul2011, Vol. 106 Issue 7, p1208 

    The article offers information on the continuing medical education (CME) activity designed for physicians in gastroenterology and hepatology on diagnostic gastrointestinal (GI) and state-of-the-art treatment of the illnesses. It states that the participants are expected to have bettered...

  • Elevated Serum Gastrin Is Associated With a History of Advanced Neoplasia in Barrett's Esophagus. Wang, Judy S; Varro, Andrea; Lightdale, Charles J; Lertkowit, Nantaporn; Slack, Kristen N; Fingerhood, Michael L; Tsai, Wei Yann; Wang, Timothy C; Abrams, Julian A // American Journal of Gastroenterology;May2010, Vol. 105 Issue 5, p1039 

    OBJECTIVES:Proton pump inhibitors (PPIs) are frequently prescribed to patients with Barrett's esophagus (BE), but in a subset, they can induce significant hypergastrinemia. Elevated levels of gastrin have been associated with tumorigenic effects in a number of gastrointestinal cancers. We...

  • Zollinger Ellison syndrome, treated with lansoprazole, during pregnancy. Mayer, Amit; Sheiner, Eyal; Holcberg, Gershon // Archives of Gynecology & Obstetrics;Sep2007, Vol. 276 Issue 2, p171 

    Zollinger Ellison syndrome (ZES), an ulcerative disease of the upper gastrointestinal tract that involves the production of high levels of gastrin and gastric acid, is a rare, symptomatic, endocrine neoplastic disease. We report a rare case of gastrinoma that was first diagnosed during pregnancy...

  • Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease. Katz, Philip O; Gerson, Lauren B; Vela, Marcelo F // American Journal of Gastroenterology;Mar2013, Vol. 108 Issue 3, p308 

    The article disuses guidelines related to treatment and diagnosis of gastroesophageal reflux disease (GERD). Prevalence of GERD on the basis of symptoms regurgitation and heartburn is discussed. Treatment of GERD includes use of histamine-receptor antagonists, antacids and proton pump inhibitor...

  • PPIs, H. pylori, and Atrophic Gastritis: Putting the Issue to Rest? DiBaise, John K.; Thompson, Jon S. // American Journal of Gastroenterology;Dec1999, Vol. 94 Issue 12, p3403 

    Discusses research being done on the effect of acid suppression therapy on the development of atrophic gastritis in individuals infected with Helicobacter pylori. Reference to a study by L. Lundell, P. Miettinen, H. E. Myrvold et al., published in the 1999 issue of the "American Journal of...

  • Switch to esomeprazole a good move in GERD.  // PharmacoEconomics & Outcomes News;7/11/2009, Issue 582, p7 

    The article deals with the results of the EncomPASS study, presented at Digestive Disease Week 2009, which showed that using proton pump inhibitors (PPIs) in gastroesophageal reflux (GERD) improves Quality-Adjusted Life-Year (QALY) scores. The researchers switched GERD therapy to esomeprazole in...

  • Wireless pH Recording Immediately Above the Squamocolumnar Junction Improves the Diagnostic Performance of Esophageal pH Studies. Wenner, Jörgen; Hall, Mats; Höglund, Peter; Johansson, Jan; Johnsson, Folke; Öberg, Stefan // American Journal of Gastroenterology;Dec2008, Vol. 103 Issue 12, p2977 

    BACKGROUND AND AIMS: The optimal position for pH electrode placement in the diagnosis of gastroesophageal reflux disease (GERD) is unknown. The aim of this study was to evaluate the discriminatory power of targeted pH recording immediately above the squamocolumnar junction (SCJ) and to compare...


Read the Article


Sign out of this library

Other Topics